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Abstract Introduction: Mild cognitive impairment (MCI) has clinical value in its ability to predict later de-
mentia. A better understanding of cognitive profiles can further help delineate who is most at risk of
conversion to dementia. We aimed to (1) examine to what extent the usual MCI subtyping using core
criteria corresponds to empirically defined clusters of patients (latent profile analysis [LPA] of contin-
uous neuropsychological data) and (2) compare the two methods of subtyping memory clinic partic-
ipants in their prediction of conversion to dementia.
Methods: Memory clinic participants (MCI, n 5 139) and age-matched controls (n 5 98) were
recruited. Participants had a full cognitive assessment, and results were grouped (1) according to
traditional MCI subtypes and (2) using LPA. MCI participants were followed over approximately
2 years after their initial assessment to monitor for conversion to dementia.
Results: Groups were well matched for age and education. Controls performed significantly better
than MCI participants on all cognitive measures. With the traditional analysis, most MCI participants
were in the amnestic multidomain subgroup (46.8%) and this group was most at risk of conversion to
dementia (63%). From the LPA, a three-profile solution fit the data best. Profile 3 was the largest
group (40.3%), the most cognitively impaired, and most at risk of conversion to dementia (68% of
the group).
Discussion: LPA provides a useful adjunct in delineatingMCI participants most at risk of conversion
to dementia and adds confidence to standard categories of clinical inference.
 2015 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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1. Introduction
Mild cognitive impairment (MCI) is a syndrome defined
as cognitive decline greater than expected for an individual’s
age and education level that does not interfere notably with
activities of daily living [1]. It is clinically valuable in the
prediction of later dementia. An annual conversion rate of
10%–15% has been widely cited, but a meta-analysis from
memory clinic settings gave a more precise annual conver-
sion rate of 9.6% to dementia [2]. Along with deficits in
memory, patients may present with deficits in language, vi-
suospatial processing, and executive function or with symp-
toms in a combination of domains [3].
There have been attempts to create subtypes of MCI
based on levels of impairment deemed to be of statistical
and clinical significance. These describe combinations of
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neuropsychological impairments. The combinations them-
selves are derived from imposed cutoff scores that divide
continuous neuropsychological data into binary variables
of impaired/not impaired and are as follows: amnestic single
domain (ASD; deficit in memory only), amnesic multido-
main (AMD; deficit in memory plus another domain e.g.,
language), nonamnestic single domain (NASD; deficit in a
single nonmemory domain e.g., executive function), and
nonamnestic multidomain (NAMD; deficits in.1 in nonme-
mory domains e.g., language and visuospatial function) [4].
Several studies have assessed these MCI subgroups and their
predictive value for conversion to dementia. Initial research
suggested ASDMCI had the least favorable outcome [5], but
more recently, the AMD type has been shown to have a less
favorable prognosis [6–8].
Advances in statistical analysis offer the opportunity to
empirically validate the Petersen and Morris (2005) [4] clas-
sifications including latent profile analysis (LPA). Although
this type of analysis has been widely used in related disci-
plines such as mental health [9], it has only been applied
twice inMCI. Both these studies demonstrated added benefit
in this type of analysis in terms of classification and maxi-
mizing predictive power for dementia conversion [10,11].
This study examined people who were assessed and diag-
nosed with MCI shortly after their entry to a memory clinic
service. The objectives of this study were as follows:
1. To examinewhether the usual MCI subtypes [4] corre-
spond to empirically defined (LPA of neuropsycholog-
ical data) clusters of patients and
2. To explore which of the two methods of categorization
of MCI participant data best predicted conversion to
dementia in the clinic.
2. Methods
2.1. Participants and diagnostic procedure
MCI participants were recruited from the Belfast City
Hospital memory clinic. This is a dual consultant-led mem-
ory service providing a regional diagnostic and treatment
service. They presented with memory problems usually
but were functionally independent and scored 24 of
30 on the mini-mental state examination (MMSE) [12]
and 82–88 of 100 on the Addenbrooke’s Cognitive
Examination-Revised (ACE-R) [13]. Participants were
diagnosed with MCI according to criteria developed by an
international working group on MCI [14]. The Office for
Research Ethics Committees Northern Ireland approved
this study (reference 06/NIR02/55). Written informed con-
sent was obtained from all participants; they were recruited
sequentially as they presented to the clinic with no age or sex
restriction. Participants with major depressive or other se-
vere psychiatric disorders were excluded, whereas those
with minor depressive and anxiety symptoms were not
(score of ,5 of 15 on the Geriatric Depression Scale
Short Version [15]). Additional exclusion criteria were any
psychoactive medication with possible impact on cognition
and chronic alcohol or drug abuse. Participants had neuroi-
maging carried out (computerised tomography or magnetic
resonance imaging brain) for differential diagnosis and
were followed up yearly through the memory clinic. The
major objective of the follow-up examination was to deter-
mine the diagnostic status of the study participants (no
cognitive impairment of clinical significance, stable MCI,
or dementia). Conversion to a diagnosis of Alzheimer’s dis-
ease (AD) was based on National Institute of Neurological
Disorders and Stroke -Alzheimer Disease and Related Dis-
orders (NINCDS-ADRDA) criteria [15]; vascular dementia
based on National Institute of Neurological Disorders and
Stroke and the Association Internationale pour la Recherche
et l’Enseignement en Neurosciences (NINDS-AIREN)
criteria [16]; and mixed dementia based on International
Classification of Diseases, Tenth Revision criteria (World
Health Organization, Geneva, 1993).
Controls were recruited from groups of volunteers that
have previously assisted with studies of this type or were
spouses of patients. They had no cognitive complaints, sub-
jectively or on objective assessment and were judged phys-
ically and mentally healthy by their clinician (B.M./P.P.).
2.2. Neuropsychological assessment
The neuropsychological evaluation comprised learning
and episodic memory, visuospatial function, language, exec-
utive function, and attention. Within each cognitive domain,
several aspects of function were assessed to obtain as com-
plete a picture as possible. The specific tests were chosen
on the basis of their demonstrated validity for use within a
population with MCI.
1. Everyday function: It was assessed using the disability
assessment for dementia [17]. Scores range from 0 to
80 with higher scores indicating higher function.
2. Premorbid intelligence quotient (IQ): It was estimated
using the National Adult Reading Test (NART) [18].
3. Immediate and delayed memory: It was tested using
the NewYork University immediate and delayed para-
graph recall test (NYU 1 and 2, respectively) [19] and
the paired associate learning (PAL) test from the Cam-
bridge Neuropsychological Test Automated Battery
(http://www.camcog.com/cantab-tests.asp).
4. Executive function and attention: These were
primarily assessed using the clock drawing task
(CLOX) 1 [20], the Stroop color word test [21], Hay-
ling sentence completion test [22], and color trails
(CTs) 1 and 2 [23].
5. Language ability: It was assessed using the controlled
oral word association test (COWAT) [24] which has
twoparts:Letterfluency (FAS)andcategoryfluency [25].
6. Visuospatial function: It was assessed using CLOX 2
[20] and the Brixton spatial anticipation test [22].
Additional to its measurement of visuospatial abili-
ties, the latter is reliant on executive functioning.
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3. MCI subclassification
Neuropsychological data were adjusted for age and
education, plotted, and examined for normality and homo-
geneity of variance (Levene’s test). Z scores were then
calculated for each neuropsychological measure relative
to the control groups’ performance. To differentiate partic-
ipants with MCI on the different cognitive domains
affected, a cutoff for each test was set at 1.5 standard devi-
ations (SD) below the control mean, thus designating this
level of impairment to be of clinical significance, as per pre-
vious studies of this type [26]. An impaired result on at least
one test in each cognitive domain was required to be consid-
ered impaired in the domain.MCI participants were then as-
signed to one of five groups on the basis of the number of
domains affected: no impairment of clinical significance
(NICS), ASD, AMD, NASD, and NAMD.
3.1. Statistical analysis
Mean neuropsychological differences between MCI and
healthy controls at time 1 (i.e., intake to the memory clinic)
were explored using t tests (with effect sizes) in SPSS
version 17. An LPAwas run on z-scores for category fluency,
CT1, CT2, Stroop, CLOX 1, CLOX 2, Hayling, Brixton,
FAS, NYU1, and NYU2 at time 1 to empirically explore
the structure of heterogeneous neuropsychological impair-
ment in MCI. LPA is based on the concept that the statistical
associations among selected continuous observed variables
are a manifestation of underlying “latent” subgroups or
classes in the study population [27]. It is a technique which
can model the skewed distributions typical of neuropsycho-
logical research, with the distributional characteristics of the
data determining the profiles generated [28]. Parameters
from the model include profile membership probabilities
for individuals with MCI and profile-specific symptom
means and variances. To avoid local maxima solutions,
two through five profiles were run using a range of random
starts and final stage optimizations ensuring the best log-
likelihood value were replicated. The final model was to
be determined using a consensus of several fit criteria
including lowest values of Akaike information criterion
(AIC) [29], Bayesian information criterion (BIC) [30], and
sample size–adjusted Bayesian information criterion (SSA-
BIC) [31]. In addition, the Lo-Mendell-Rubin likelihood ra-
tio test (LMR–LRT) compares a k-profile solution to k21
profile solution, where k is a given number of latent profiles.
If the probability value (P) is ,.05, the k model is superior
and additional profiles are added until the P value for the sta-
tistic is ..05. At this point, the k and k21 models are
considered to fit equivalently, typically the previous (k21)
model is accepted for reasons of parsimony; however, the
k model may be preferred if supported by other criteria
including the theoretical relevance and distinctiveness of
the additional profile [32]. A range of random starts and final
stage optimizations was ran on each of the two to avoid local
maxima solutions. Entropy is a measurewhich indicates how
distinct the latent profiles are from one another; a number
close to one suggests a clear classification [33].
Once a suitable latent profile structure of MCI was
determined, the latent profile model parameters were fixed,
thus the correlates did not affect the formation of the latent
variable. The conditional probabilities of individuals were re-
gressed on sex (1 5 male; 2 5 female), age (in years),
numbers of years education, NART-IQ, and two dummy-
coded variables indicating status at follow-up as either normal
(51, all other valid values 5 0) or progressed to dementia
(51, all other valid values 5 0). The reference category for
this logistic regression model was the profile with the highest
impairment. This provides an opportunity to explore the val-
idity of the latent variable (e.g., [9]). Both LPA and regres-
sions were performed using Mplus version 6.01 (34) [34].
Finally, the latent profiles were cross tabulated with the Pe-
tersen and Morris (2005) [4] categories using SPSS version
17 to understand the overlap between categorizations.
4. Results
4.1. Characteristics of MCI participants versus healthy
controls
Over a two and a half year period, 237 participants were
recruited: 139 participants with MCI and 98 controls. Demo-
graphic and clinical characteristics are listed in Table 1.
Groups were well balanced on most variables but differed
on the MMSE and the ACE-R; the MCI group had poorer
performance than the control group, as might be expected,
on these measures.
4.2. Neuropsychological performance of MCI patients at
entry to the service (time 1)
Table 2 lists the mean neuropsychological test results in
the two study groups at time 1. The MCI group performed
Table 1
Characteristics of MCI and control participants
MCI,
n 5 139
Control,
n 5 98
t(df); P or
c2(df); P
Age, y, mean (SD) 72.84 (9.47) 74.73 (9.01) 21.55 (237); .12
Range, min–max 43–93 52–94
NART IQ,
mean (SD)
113.71 (8.47) 113.48 (8.41) 0.20 (237); .84
Years of education,
mean (SD)
12.17 (3.0) 11.61 (3.1) 1.48 (237); .14
MMSE, mean (SD) 27.88 (1.69) 29.38 (0.82) 28.11 (237); .01
ACE-R, mean (SD) 84.78 (5.70) 91.60 (4.39) 22.22 (237); .03
DAD, mean (SD) 79.51 (1.01) 79.61 (2.16) 20.50 (237); .62
Sex F:M (%) 81:58 (58:42) 54:44 (55:45) 0.24 (2); .63
Abbreviations: MCI, mild cognitive impairment; df, degree of freedom;
SD, standard deviation; NART, National Adult Reading Test; IQ, intelli-
gence quotient; MMSE, mini-mental state examination; ACE-R, Adden-
brooke’s Cognitive Examination-Revised; DAD, disability assessment in
dementia.
NOTE. P values are indicated for the comparison between the MCI and
control groups by unpaired t-test (significant P values are shown in bold)
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significantly worse than healthy controls on all cognitive
tests.
4.3. Neurocognitive decline and conversion to dementia
MCI patients were followed for a mean of 18.4 months
(SD, 10.2 months). Seventy-one patients remained stable
at follow-up, 11 showed improvement to normal, 41 patients
developed AD, one developed vascular dementia (VaD), and
two developed mixed dementia; 13 patients were lost to
follow-up due to illness (n 5 9), moving from the area
(n 5 2), and death (n 5 2). As there were such small
numbers in the VaD and mixed dementia groups, these
participants were added to the AD group to provide a final
dementia diagnosis. There was adequate full neuropsycho-
logical follow-up in 116 patients from the neurocognitive
study (23 patients had incomplete data collection) to allow
for subdivision into cognitive domains. Category/subtype
of MCI at time 1 and risk of progression to dementia were
analyzed using Cox proportional hazard ratio (HR) in addi-
tion to a Kaplan-Meier analysis (Fig. 1). Two of 22 (9.1%)
MCI participants from the NICS group, 1 of 12 (8.3%)
from the ASD group, 35 of 55 (63.6%) from the AMD group,
3 of 19 (15.7%) from the NASD, and 2 of 8 (25.0%) from the
NAMD group converted to dementia. When compared with
the NICS group, the HR for conversion to dementia was 0.6
(95% confidence interval [CI], 0.1–6.2) in the ASD group,
3.9 (95% CI, 0.9–16.5) in the AMD group, 1.2 (95% CI,
0.2–7.2) in the NASD group, and 1.6 (95% CI, 0.2–11.7)
in the NAMD group. The HR for conversion to dementia
was 3.7 (95% CI, 1.7–8.0) in the AMD group compared
with all other groups (P 5 .001). Rate of conversion from
MCI to dementia was 15.7% per year. Of note, those who
converted to dementia were significantly older at time 1
than those who remained stable or improved (F 5 9.2,
P , .01); MMSE and ACE-R score at time 1 were also
significantly lower in those who converted to dementia
compared with those who remained stable or improved
(F 5 6.2, P , .0; F 5 6.4, P , .01, respectively).
4.4. Latent profile analysis
The fit criteria for the latent profile analysis on 139
patients are given in Table 3. The AIC and SSABIC informa-
tion criterion continued to decline with the addition of
further latent profiles and were, thus, inconclusive; the
lowest value of BIC suggested a four-profile solution was
preferred. The LRT suggested a three-profile solution and
a two-profile solution fitted equivalently well. Fit criteria
were not equivocal in highlighting the best fitting model.
Consequently, and with parsimony in mind, the two-,
three-, and four-profile solutions were inspected. The two-
and three-profile solution fit the data equivalently well
Table 2
Baseline neuropsychological performance of MCI and control participants
Domains
MCI n 5 139,
mean score (SD)
Controls n 5 98,
mean score (SD) t(df) P Cohen’s d
Immediate and delayed memory
NYU immediate paragraph recall (words recalled) 3.6 (2.2) 5.6 (2.3) 26.7 (236); ,.01 0.89
NYU delayed paragraph recall (words recalled) 3.8 (3.1) 7.0 (2.8) 28.2 (236); ,.01 1.00
PAL stage reached 6.0 (1.5) 6.7 (0.9) 23.0 (236); ,.01 0.56
Executive function and attention
CLOX1 11.0 (2.7) 12.0 (2.1) 23.1 (236); ,.01 0.41
Color trails 1 (s) 83.9 (39.7) 64.6 (22.8) 4.7 (236); ,.01 0.59
Color trails 2 (s) 165.3 (65.2) 133.2 (46.5) 4.4 (236); ,.01 0.57
Stroop color word (number in 45 s) 24.5 (10.7) 29.8 (9.5) 23.9 (236); ,.01 0.52
Hayling sentence completion (total performance) 13.4 (3.4) 15.5 (3.4) 24.4 (236); ,.01 0.62
Language
COWAT letter fluency 10.8 (4.3) 12.3 (4.2) 22.6 (236); .01 0.35
COWAT category fluency 13.6 (4.5) 16.8 (3.7) 25.8 (236); ,.01 0.78
Visuospatial function
CLOX 2 13.1 (1.5) 13.8 (1.3) 23.8 (236); ,.01 0.50
Brixton spatial anticipation test (numberof errors) 18.3 (8.0) 15.4 (6.2) 2.8 (236); ,.01 0.40
Abbreviations: MCI, mild cognitive impairment; SD, standard deviation; NYU, New York University; PAL, paired associate learning; COWAT, controlled
oral word association test.
Fig. 1. Kaplan-Meier analysis of risk of conversion to dementia using
Petersen and Morris criteria.
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according to the LRT. The addition of a third profile pro-
vided a qualitatively different neurocognitive profile to the
existing two profiles; however, the four-profile solution did
not provide four qualitatively distinct profiles. As such, the
three-profile solution was preferred.
The largest profile group (profile 3) displayed the greatest
degree of neuropsychological impairment at around 40%
(n 5 56) of the sample (Table 3). This grouping scored
below 1 SD from mean performance on the cognitive tests
examined, with category fluency, CT 1, and NYU 2 all 1.5
SD belowmean performance.Wewould consider this profile
to be best described as multiple deficit MCI.
The next largest group was profile 1 (36.7%; n 5 51).
This group was characterized by deficits primarily in NYU
1 and NYU 2 (.1 SD below the mean) along with less sig-
nificant deficits in a number of other domains (at least 0.5 SD
below the mean on category fluency and Hayling) but with
CT 1 and CT 2 scores above the mean. This group most
likely corresponds to a memory deficit MCI. Finally, there
was a third group with scores generally around the mean
for this sample (profile 2; n 5 32), and with scores slightly
above the mean on Brixton, NYU 1, and NYU 2; this group
may best be described as least cognitively impaired.
However, to validate these three classes, a regression was
run using the proportional membership for individuals in
each profile. The odds ratios and 95% CIs are given in
Table 4. From this, it can be seen that higher IQ and younger
age were associated with membership of profile 2 compared
with profile 3, and both membership of profiles 1 and 2
significantly differed from profile 3 in relation to change in
MMSE with profiles 1 and 2 showing considerably higher
odds of improving to normal, and considerably lower odds
of progression to dementia on follow-up. The least cogni-
tively impaired group unsurprisingly appeared less likely
to progress to dementia and more likely to improve to
normal than the memory deficit group.
On investigation of LPA naming, we found some agree-
ment with the subtypes that were broadly derived from the
Petersen andMorris (2005) criteria [4] (Table 5). Those clas-
sified as having NICS according to original criteria had most
common overlap with profile 2, (56%) with the remainder in
profile 1 (Table 4). The classification of ASD was almost
entirely found in profile 1. The NASD had some overlap
with profile 1 (31%) but most overlap with profile 2
(58%). The two “multidomain” categories were most
commonly found in profile 3 as might be expected.
Nine of 47 participants (19.1%) in profile 1, 2 of 22 (9.1%)
in profile 2, and 32 of 47 (68%) in profile 3 converted to de-
mentia during follow-up (Fig. 2). Compared with profile 2,
the HR for conversion to dementia was 1.5 (95% CI, 0.3–
6.9) in profile 1 and 5.0 (95% CI, 1.2–21.1) in profile 3.
The HR for conversion to dementia was 3.7 (95% CI, 1.8–
7.4) in profile 3 compared with the other profiles (P , .001).
5. Discussion
Initial analyses showed the MCI participants were
impaired on all cognitive tests compared with the control
group. As in previous studies, most MCI participants were
in the AMD subgroup (46.8%) [26,35,36]. The Goteborg
MCI study [26] found a small percentage of MCI subjects
could be categorized as ASD (1.8%) and 17% showed no
impairment compared with controls, similar to the results re-
ported here.
The AMD group of MCI participants was most at risk of
conversion to dementia. Again, this has been found in several
other studies [7,8]. Themisconception that ASDMCI has the
worst prognosis was also disproved: the category of ASD
MCI was the most benign in terms of conversion and this
replicates previously mentioned studies [7,8].
When an LPAwas carried out, a three-profile solution was
obtained. There was some agreement with the most likely
latent profiles and the subtypes derived from the Petersen
andMorris criteria (2005) [4]. Profile 3 was the largest group
and most neuropsychologically impaired. This was felt to
most closely represent the previously described AMD group,
although there was some overlap also with the NAMD
Table 3
Standard deviations below the mean in each neurocognitive test
Neurocognitive
test
Profile 1:
Memory
deficit, n 5 51
Profile 2: Least
cognitively
impaired, n 5 32
Profile 3:
Multiple
deficit, n 5 56
Category fluency 20.84 20.14 21.72
CT1 0.14 20.25 21.62
CT2 0.12 20.08 21.48
Stroop 20.26 20.07 21.48
CLOX 1 20.17 20.08 21.21
CLOX 2 20.55 20.03 21.12
Hayling 20.80 20.30 21.21
Brixton 20.36 0.07 21.32
Letter fluency 20.11 20.08 21.01
NYU 1 21.07 0.27 21.36
NYU 2 21.43 0.34 21.76
Abbreviations: CT, color trails; NYU, New York University.
Table 4
Odds ratios and 95% confidence intervals between predictors and latent
profile membership
Profile 1:
Memory deficit
Profile 2: Least
cognitively impaired
Age, continuous years 0.99 (0.94–1.05) 0.92 (0.86–0.99)*
Sex, female 0.76 (0.35–1.66) 0.80 (0.27–2.38)
Education level, years in
education
0.98 (0.83–1.14) 0.92 (0.75–1.13)
NART IQ score 0.99 (0.94–1.05) 1.09 (1.01–1.18)*
Improved to normal at
follow-up
14.99 (2.84–79.10)* 41.33 (4.62–260.03)*
Progressed to dementia at
follow-up
0.18 (0.08–0.40)* 0.11 (0.02–0.60)*
Abbreviations: NART, National Adult Reading Test; IQ, intelligence quo-
tient; MCI, mild cognitive impairment.
NOTE.Using profile 3:Multiple deficitMCI as reference category figures
in bold and * denotes significance at .05 level.
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group. In this profile group, category fluency, CT 1, and
NYU 2 were most impaired in keeping with deficits across
several domains. A previous study using LPA in cognitively
normal individuals demonstrated poor performance in CT 2
and delayed recall significantly predicted later cognitive
impairment [37]. This study illustrated a similar pattern in
MCI participants.
Profile 1 contained 92% of the previously defined ASD
group. This group had considerable deficits in memory and
smaller deficits in verbal fluency and executive function.
Some individuals in profile 1, however, had no impairment
of clinical significance with individual mean scores around
the mean for some of the neuropsychological indicators.
Profile 2 contained most of the previously ascribed no
NICS or NASD group with preserved memory and recall
and very small deficits in executive function.
Interestingly, those in the least impaired profile 2 were
younger and had a higher IQ compared with those in profile
3. These participants had health seeking behavior regarding
their memory but on in-depth neurocognitive testing were
mostly found to have NICS. There may be protective ele-
ments from younger age and higher IQ at play. The cognitive
reserve hypothesis postulates that cognitive reserve in the
form of higher IQ, education, or occupational attainment re-
duces the prevalence of cognitive decline [38]. Profiles 1 and
3 did not differ in terms of years of education but in terms of
premorbid IQ. Assessment of IQ has been shown to be a
more accurate estimation of optimal cognitive functioning
than years of education especially in an older cohort who
do not accurately remember their years of education [39].
Older age was a significant predictor of decline in the
traditional analysis and its impact is borne out again in the
LPA analysis; participants in profile 3 similar to the AMD
group were older and were significantly more likely to
convert to dementia and significantly less likely to improve
to normal at time 2. This has been demonstrated previously
in similar studies [40,41] where age was either a very
significant variable or the only variable influencing
likelihood of conversion to dementia. Lower MMSE at
entry has also been demonstrated previously as a
significant risk factor for conversion to dementia; similar
to this study [40,41].
MCI is a highly heterogeneous construct that defines the
gray area between intact cognitive functioning and clinical
dementia. The construct has evolved over the past 10 years,
but controversial issues in classification remain due to differ-
ences in operationalization of the original criteria, differ-
ences in the setting, selection of subjects, and length of
follow-up in longitudinal studies [42]. The five Petersen
and Morris criteria were found in our sample, and the neuro-
cognitive battery revealed three distinct profiles when LPA
was used to empirically explore the scores. A previous study
[11] discovered five latent classes within a group of MCI and
subjective memory impairment participants but they did not
include visuospatial function or language within their neuro-
psychological battery. Our study included assessment of all
neurocognitive domains so can be considered more exten-
sive in this regard. Not finding similar profiles in this data
may have been a function of (1) the sample size and vari-
ability, (2) the additional neurocognitive tests, or (3) as a
function of the relationships between the domains in the
data. Confirmatory latent variable modeling in subsequent
data sets may help to understand differences, and we recom-
mend using the wide range of neurocognitive tests as used
here to better represent the clinically defined condition.
Our study demonstrated both methods were useful in
predicting conversion to dementia with identical HR for
conversion to dementia in the AMD group and profile 3.
This reinforces the fact that impairment in more than one
Table 5
Classification of MCI participants According to the methods of Petersen and Morris (2005)
Group categorization by
Petersen criteria
Number of MCI
patients (%)
Of the total MCI patients in each category, breakdown in each profile (from LPA)
Profile 1: Memory
deficit, n 5 51 (36.7%)
Profile 2: Least cognitively
impaired, n 5 32 (23.0%)
Profile 3: Multiple
deficit, n 5 56 (40.3%)
No impairment of clinical significance 25 (18.0) 11 (44.0) 14 (56.0) 0 (0.0)
Amnestic single domain 13 (9.4) 12 (92.3) 1 (7.7) 0 (0.0)
Amnestic multidomain 65 (46.8) 17 (26.2) 1 (1.5) 47 (72.3)
Nonamnestic single domain 26 (18.7) 8 (30.8) 15 (57.7) 3 (11.5)
Nonamnestic multidomain 10 (7.2) 3 (30.0) 1 (10.0) 6 (60.0)
Abbreviations: MCI, mild cognitive impairment; LPA, latent profile analysis.
Fig. 2. Kaplan-Meier analysis of risk of conversion to dementia using latent
profile analysis.
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cognitive domain places one at greater risk of conversion to
dementia. Membership of other Petersen and Morris (2005)
classifications or latent profiles appears relatively benign
and so patients in these groups could be reassured regarding
their risk of conversion to dementia.
Shortfalls of our study include short follow-up time and
attrition rate. Follow-up was limited by funding constraints,
and high attrition is a risk factor in longitudinal studies in the
elderly; mean age in our MCI group was 72.8 years and par-
ticipants had multiple comorbidities. One–2 year follow-up,
however, provides data during the most clinically relevant
period for management of those with MCI.
The use of LPA to explore the patterns of neurocognitive
deficit is a useful addition to better understanding the differ-
ences between patients. To the best of our knowledge, this
is the first study to explore MCI in this way. In order for
this method to be useful in a clinical setting, future research
should attempt replication and validation in similar samples,
and a comparison of latent class and latent profile methods.
The exploration of these profiles in terms of patient-
reported outcomes and other clinical outcomes would also
be greatly welcomed.
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RESEARCH IN CONTEXT
1. Systematic review: Previous research was identified
by an online search (using PubMed) of neurocogni-
tive studies in mild cognitive impairment (MCI)
and of latent profile analysis in dementia/MCI. Re-
sults from the searches were collated and assessed
by two authors (B.M. and G.W.S.). Relevant studies
were referenced in the text.
2. Interpretation: Findings from this study contribute to
the knowledge base regarding cognitive profiles of
MCI and their risk of conversion to dementia. Am-
nestic multidomain MCI participants were most at
risk of conversion and this finding adds to the litera-
ture base in this area. We used latent profile analysis,
a novel statistical analysis in this cohort of partici-
pants to empirically define extent of impairment.
3. Future directions: Future research should attempt
replication of the patterns and follow participants
over a longer period of time.
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